JANE RUPP: Open Payments
NPI 1881469237 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,218 in 90 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $1,405 · 2025 $2,218
Food & beverage: $2,218
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 30 | $730 |
| ABBVIE INC. | 20 | $485 |
| Ardelyx, Inc. | 12 | $408 |
| Gilead Sciences, Inc. | 11 | $294 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $174 |
| VIVUS LLC | 4 | $86 |
| Ipsen Biopharmaceuticals, Inc | 2 | $41 |
Products named: REZDIFFRA, IBSRELA, LINZESS, XIFAXAN, MAVYRET, PANCREAZE, CREON, VIBERZI.
Industry payments across NY — which companies pay providers there.
